Anti-Acne Activity of Italian Medicinal Plants Used for Skin Infection by Kate Nelson et al.
ORIGINAL RESEARCH
published: 10 November 2016
doi: 10.3389/fphar.2016.00425
Frontiers in Pharmacology | www.frontiersin.org 1 November 2016 | Volume 7 | Article 425
Edited by:
Adolfo Andrade-Cetto,
National Autonomous University of
Mexico, Mexico
Reviewed by:
Tom Coenye,
Ghent University, Belgium
Adeyemi Oladapo Aremu,
University of KwaZulu-Natal,
South Africa
*Correspondence:
Cassandra L. Quave
cquave@emory.edu
Specialty section:
This article was submitted to
Ethnopharmacology,
a section of the journal
Frontiers in Pharmacology
Received: 30 August 2016
Accepted: 26 October 2016
Published: 10 November 2016
Citation:
Nelson K, Lyles JT, Li T, Saitta A,
Addie-Noye E, Tyler P and Quave CL
(2016) Anti-Acne Activity of Italian
Medicinal Plants Used for Skin
Infection. Front. Pharmacol. 7:425.
doi: 10.3389/fphar.2016.00425
Anti-Acne Activity of Italian Medicinal
Plants Used for Skin Infection
Kate Nelson 1, James T. Lyles 2, Tracy Li 2, Alessandro Saitta 3, Eugenia Addie-Noye 2,
Paula Tyler 4 and Cassandra L. Quave 1, 2, 5*
1Department of Dermatology, Emory University School of Medicine, Atlanta, GA, USA, 2Center for the Study of Human
Health, Emory University College of Arts and Sciences, Atlanta, GA, USA, 3Department of Agricultural and Forest Sciences,
Università Degli Studi di Palermo, Palermo, Italy, 4Department of Chemistry, Emory University College of Arts and Sciences,
Atlanta, GA, USA, 5 Antibiotic Resistance Center, Emory University, Atlanta, GA, USA
Propionibacterium acnes is implicated in the pathogenesis of acne vulgaris,
which impacts >85% of teenagers. Novel therapies are in high demand and
an ethnopharmacological approach to discovering new plant sources of anti-acne
therapeutics could contribute to filling this void in effective therapies. The aims of our
study were two-fold: (1) To determine if species identified in ethnopharmacological
field studies as having traditional uses for skin and soft tissue infection (SSTI) exhibit
significantly more activity against P. acnes than species with no such reported use; and (2)
Chemically characterize active extracts and assess their suitability for future investigation.
Extracts of Italian medicinal (for acne and other skin infection) and randomly collected
plants and fungi were screened for growth-inhibitory and anti-biofilm activity in P. acnes
using broth microdilution methods. Bioactive extracts were chemically characterized by
HPLC and examined for cytotoxicity against human keratinocytes (HaCaTs). Following
evaluation of 157 extracts from 10 fungi and 58 plants, we identified crude extracts from
seven species exhibiting growth inhibitory activity (MICs 64–256 µg mL−1). All active
extracts were examined for cytotoxicity against HaCaTs; extracts from one fungal and
one plant species were toxic (IC −150 256µgmL ). HPLC analysis with chemical standards
revealed many of these extracts contained chlorogenic acid, p-coumaric acid, ellagic
acid, gallic acid, and tannic acid. In conclusion, species used in traditional medicine for
the skin exhibited significantly greater (p < 0.05) growth inhibitory and biofilm eradication
activity than random species, supporting the validity of an ethnobotanical approach to
identifying new therapeutics. The anti-acne activity of three extracts is reported for the
first time: Vitis vinifera leaves, Asphodelus microcarpus leaves, and Vicia sativa aerial
parts.
Keywords: biofilms, antimicrobials, antibiotics, acne, medicinal plants, Propionibacterium acnes,
ethnopharmacology
INTRODUCTION
Acne vulgaris is a common skin disorder affecting more than 85% of teenagers in the United
States (James et al., 2009). While it is not a lethal or debilitating disorder, it can be painful
and disfiguring, causing significant physiological distress, and heavy economic burden. Acne is
associated with increases in anxiety, depression, and suicidal ideation (Dunn et al., 2011). In 2001,
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a report estimated that over $1 billion is spent each year in the US
on acne related health care visits and acne therapies (Lehmann
et al., 2001). However, these therapies are not cures, but rather
ways of managing this follicular disorder.
Current treatments fall into either two categories: topical
or oral. Common topical treatments include benzoyl peroxide,
retinoids, and antibiotics (i.e., erythromycin or clindamycin),
and common oral treatments include retinoids and antibiotics
(i.e., tetracycline and macrolides; Layton, 2016; Zaenglein et al.,
2016). In cases of severe acne, combinational treatments are used,
usually employing benzoyl peroxide, retinoids, and/or antibiotics
together (Layton, 2016; Zaenglein et al., 2016). Antibiotics have
been used for over 50 years to treat acne and today one course of
topical or systemic treatment typically lasts 3–6 months (Walsh
et al., 2016). Antibiotics are thought to inhibit inflammation
indicative of acne when used topically and systemically, as well as
target P. acneswhen used topically (Walsh et al., 2016). Likemany
other bacteria, P. acnes is also subject to emerging antibiotic
resistance and novel therapies are in high demand worldwide
(Sardana et al., 2015; Del Rosso and Zeichner, 2016; Walsh et al.,
2016). Pathogenesis targets, such as quorum sensing and biofilms,
are organism specific and could limit resistance development
(LaSarre and Federle, 2013).
Biofilms contribute to the recalcitrant nature of acne by
presenting a physical barrier to which few molecules are capable
of penetrating, allowing the bacteria within to persist and cause
infection (Donlan, 2001; Vlassova et al., 2011). Biofilms have been
implicated in implant-related and chronic infections (Donlan,
2001; Aubin et al., 2014), accounting for an estimated 80% of
microbial infections in the body (Sun et al., 2013). P. acnes has
been detected in biofilms associated with bone, joint and spinal
prosthetics, breast implants, external ventricular shunts, and,
in rare instances, cardiac devices (Aubin et al., 2014). P. acnes
biofilms are associated with pathogenesis of acne, with extensive
biofilm growth being associated with acne vulgaris (Jahns and
Alexeyev, 2014). The high incidence of antibiotic resistance seen
in P. acnes worldwide is thought to be due to biofilms, as well
as the high use of antibiotics (Sardana et al., 2015; Walsh et al.,
2016). Only a few studies have evaluated potential P. acnes anti-
biofilm compounds (Brackman et al., 2014; Sivasankar et al.,
2016) and to the best of our knowledge only one study has
evaluatedmedicinal plants for anti-biofilm activity (Coenye et al.,
2012). Medicinal plants, in particular, may present a unique
source of new therapeutic options. Many studies have been
dedicated to documentation of traditional uses of medicinal
plants for managing dermatological conditions, and these may
represent a strong starting point for drug discovery research on
this topic (Pieroni et al., 2004b; Quave et al., 2008b; Cavero et al.,
2013; Mabona and Van Vuuren, 2013; Afolayan et al., 2014; Lall
and Kishore, 2014).
An ethnobotanical approach for drug discovery uses
traditional medicine, historical texts or traditional healers,
as a guide toward potentially medicinal plant species. A
number of studies addressing different biological targets have
demonstrated that an ethnobotanical approach to identifying
bioactive compounds in plants is more efficacious than a random
search. More than 15 years ago, Slish et al. (1999) compared
plant species of which 31 had an ethnobotanical use and
32 were random collections. The random collection extracts
had no vasorelaxation activity, but 19% of ethnobotanical
extracts did (Slish et al., 1999). Another study focused on
the search for antifungal activity compared 114 extracts with
antifungal ethnobotanical use and 183 extracts with either no
ethnobotanical indication or non-fungal ethnobotanical use. In
a series of bioassays, extracts in the ethnobotanical indication
group consistently had higher hit rates with the antifungal
indicated extracts; 40% had antifungal activity against at least
one fungus vs. 21% of plants with no anti-fungal ethnobotanical
use (Svetaz et al., 2010). Similarly, a study comparing three
groups, skin and soft tissue infection (SSTI) botanicals, non-skin
botanicals, and random plants, for their Staphylococcus aureus
antibacterial and anti-biofilm actions found no difference
between the three groups for antibacterial activity, but SSTI
ethnobotanicals had more anti-biofilm potential in S. aureus
models than the random collections (Quave et al., 2008a).
Investigating antibacterial bioactivities beyond bacteriostatic or
bactericidal action, such as pathogenesis factors, could reveal
other mechanisms through which plant secondary metabolites
impact pathogen survival and fitness, increasing the chance of
discovering new therapeutics. For the purposes of clarity, here we
use SSTI to refer to infections of the skin and soft tissues ranging
from mild to severe, including those that are purulent (acne,
furuncles, abscesses, carbuncles) to non-purulent (necrotizing
infection, cellulitis, erysipelas) in nature.
Our research group has already demonstrated interesting
anti-staphylococcal activity (in terms of growth, biofilm, and
quorum sensing inhibitory action) in the Quave Natural Products
Library (QNPL), which includes a collection of plant and fungal
extracts derived from natural ingredients used specifically in the
treatment of SSTIs—caused by a number of skin pathogenic
bacteria, including Propionibacterium acnes—and other health
concerns in the Mediterranean and other parts of the world
(Quave et al., 2012, 2015). Extracts from Italian species in
the QNPL are uniquely tied to ethnopharmacological data
documented in field studies conducted by Quave and colleagues,
and the detailed reports of ethnopharmacological uses of these
species have been previously published (Pieroni et al., 2002,
2004a,b; Pieroni and Quave, 2005; Quave et al., 2008b).
The QNPL has only been tested against a limited number of
pathogens responsible for SSTIs, and has never been screened for
activity against P. acnes. In this study, we compare the activity of
Italian plants and fungi in the QNPL that were identified as being
used in traditional medicine for the treatment of acne and other
skin infections to a random collection of Italian species with no
reported topical applications for skin infection or inflammation.
The overall aim of this study is to compare activity of these
two groups through examination of their anti-acne potential
against planktonic and biofilm-associated P. acnes and evaluate
active extracts for future investigation. We hypothesize that
extracts from medicinal plants or fungi used for the traditional
treatment of SSTIs will demonstrate greater anti-bacterial activity
against P. acnes (in terms of killing planktonic cells and
eradicating biofilms) than those with no reported application to
the skin.
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MATERIALS AND METHODS
Plant and Fungal Materials
Plant materials were collected in Spring-Summer (May–August)
over a period of 2006–2013 from the Vulture Alto-Bradano
region of Basilicata, Italy and imported to the United States
(US) under US Department of Agriculture permits (PCIP-14-
00388; PDEP-09-0228; DP63438). All specimens were collected
following the World Health Organization (WHO) guidance
on the collection of wild medicinal plants (WHO, 2003).
All collections were made on private lands with permission
of landowners. Voucher specimens were deposited at the
Herbarium Lucanum (HLUC) at the Universitá della Basilicata
in Potenza, Italy, and the Emory University Herbarium (GEO) in
Atlanta, GA, USA. Identification of species followed the standard
Italian flora (Pignatti, 2002), and family assignments followed
the Angiosperm Phylogeny Group III guidance (Tropicos.Org,
2015). Bulk materials were separated by part (e.g., leaves, stems,
flowers, roots), cut into small pieces with clippers, and then dried
in a plant drier with a heat source (35◦C) and fan for 48–72 h,
until completely dried. Samples were packed with silica packets
and vacuum sealed before shipping to the lab for extraction and
analysis. Upon arrival, plant materials were ground into a fine
powder using a Wiley mill (2 mmmesh size; Wiley Scientific).
Fungi were collected in December 2013 and April–November
2014 from locations in Sicily and imported to the US under
USDA permit (P526P-14-02182). Fungal collections were made
in broad-leaved and coniferous forests, preserved in paper
bags and then transported to the laboratory, dried, and
identified. Identification of fungi was carried out using fresh
or dried sporomes using European monographs (Ryvarden
and Gilbertson, 1993–1994). Species nomenclature followed the
Index Fungorum (IF, 2015). Bulk materials were dried and
processed as described above. Retention vouchers of the fungal
material are stored in the Quave lab.
Extracts from species included in this study were sorted into
groups based on history of traditional use for or not for acne and
other SSTI treatments, as documented in previously published
findings from ethnopharmacological field studies conducted in
Italy (Pieroni et al., 2002, 2004a,b; Pieroni and Quave, 2005;
Quave et al., 2008b). Importantly, these prior studies included
reports of voucher specimens, use-citations, and detailed data on
local preparation and application of the natural remedies.
Natural Product Extractions
Crude plant extracts were made as macerations in either 95%
EtOH or 100% MeOH with a ratio of 1 g (plant material):10 mL
organic solvent for two successive periods of 72 h, with daily
agitation. Filtered extracts were combined and concentrated at
reduced pressure with rotary evaporators (<40◦C water bath
temperature), shell frozen, and then lyophilized. Extracts were
then suspended in DMSO at a stock concentration of 10mg
mL−1 prior to bioassay testing, with DMSO representing<1.28%
of the final well volume for all tests. Aqueous extracts were
created by boiling ground plant material in dH2O for 20 min
(ratio of 1 g:10 mL), followed by filtration, rotary evaporation
and lyophilization as described above. Aqueous extracts were
then prepared at a stock concentration of 10mg mL−1 in dH2O
and filtered at 0.2 µm prior to use in bioassays. Fungal extracts
were prepared in 100% MeOH or dH2O by double sonication at
room temperature for 20 min at a ratio of 1 g:10 mL, followed
by filtration, concentration and stock preparation as described
for plant extracts. In addition to the crude extracts, we also
included bioactive fractions 220D-F2 (from Rubus ulmifolius)
and 224C-F2 (from Castanea sativa) in the panel of tested
extracts. The methods for creation of these refined fractions have
been previously published (Quave et al., 2012, 2015).
Microbial Strains and Culture Conditions
The P. acnes isolate was obtained from the American Type
Culture Collection (ATCC R© 6919TM). The strain was streaked
from freezer stock onto Tryptic soy agar plates (TSA)
supplemented with 5% sheep blood (BD, Franklin Lakes, NJ)
and incubated at 37◦C for 72 h prior to making liquid cultures
in brain heart infusion (BHI) broth (BD, Franklin Lakes, NJ)
supplemented with 1% dextrose (Fisher Scientific, Waltham,
MA) (additional 72 h incubation) for use in the below described
assays. All cultures were grown in anaerobic chambers using the
EZ Anaerobe Chamber (BD, Franklin Lakes, NJ) and GasPak EZ
Anaerobe container sachets (BD, Franklin Lakes, NJ).
Minimum Inhibitory Concentration (MIC)
for Growth
There are no established Clinical and Laboratory Standard
Institute (CLSI) guidelines for MIC testing in P. acnes. Thus, we
followed previously described methods with some modifications
(Tsai et al., 2010). Briefly, liquid culture was standardized to 5 ×
107 CFUmL−1 by optical density (0.05 at OD590nm) in fresh BHI
supplemented with 1% dextrose, and this was confirmed with
plate counts. Our initial screen of the QNPL was undertaken in
96-well plates (Greiner Bio-One International, Monroe, NC) at a
final well-concentration of 256µgmL−1 (<1.28%DMSO in well)
in a total well volume of 200 µL. The OD600nm of plates was read
with a Cytation 3 multimode plate reader (BioTek, Winooski,
VT) prior to incubating under anaerobic conditions for 72 h at
37◦C. A second OD read was taken at 72 h post-inoculation,
and the final percent inhibition of growth was determined using
a previously reported formula (Quave et al., 2008a) which takes
into account any interference due to color of the test extracts. The
most active extracts (% inhibition ≥50%) were retested by serial
dilution from 2 to 256 µg mL−1 to determine concentrations
required for MIC50 and MIC90. The MIC50 and MIC90 values
were defined as the minimum concentration necessary to achieve
≥50 and ≥90% inhibition of growth, respectively.
Minimum Biofilm Eradication
Concentration (MBEC)
A previously described method was followed with modifications
(Coenye et al., 2007). Briefly, liquid culture was standardized as
described above for MIC testing. Biofilms were established in
tissue culture treated U-bottom 96-well plates (TPP, Trasadingen,
Switzerland). Following 24 h incubation under anaerobic
conditions, media was gently aspirated by manual pipetting and
extract treated media or control -resveratrol (MP Biomedicals,
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Santa Ana, CA), was added. Initial screens were conducted
at a final well-concentration of 256 µg mL−1 in a total well
volume of 100 µL. Established biofilms were exposed to extract
treatment for 24 h under anaerobic conditions, and then media
was aspirated, wells gently rinsed with PBS, heat-fixed at 37◦C
for 60 min in an oven and stained with crystal violet (Hardy
Diagnostics, Santa Maria, CA) for 15 min. Excess crystal violet
was washed off the plates in water and the plates were dried
prior to eluting the stain with 10% Tween 80 (2.5% aqueous
preparation) in EtOH. The eluate was diluted at a ratio of 1:10
in PBS and the final OD595nm measured with a plate reader.
The most active extracts (% inhibition ≥50%) were retested by
serial dilution from 2 to 256 µg mL−1 to determine MBEC50
and MBEC90. The MBEC50 and MBEC90 values were defined as
the minimum concentration necessary to achieve≥50 and≥90%
eradication of attached biofilm, respectively.
Cytotoxicity Analysis
Human immortalized keratinocytes (HaCaT) were used to
evaluate the potential skin toxicity of the most active extracts
identified via MIC and MBEC testing. Cells were maintained in
Dulbecco’s modified Eagle’s mediumwith glucose at 4.5 g L−1 and
L-glutamine (Corning, Corning, NY). Media was supplemented
with 10% heat-inactivated fetal bovine serum (Seradigm, Randor,
PA) and a solution of 100 IU Penicillin and 100 µg mL−1
Streptomycin (Corning, Corning, NY). Cells were cultured in 75
cm2 flasks incubated at 37◦C with 5% CO2. A solution of 0.25%
trypsin and 0.1% EDTA in HBSS (Corning, Corning, NY) was
used to detach cells from the bottom of the flask before splitting
and plating.
After reaching at least 80% confluence in the flask, cells
were seeded to a 96-well tissue culture plate (Fisher Scientific,
Waltham, MA). Cells were resuspended, counted with a
hemocytometer, and standardized to a concentration of 4 ×
104 cells per mL (8 × 103 cells per final 200 µL well volume).
Plates were incubated for 48 h at 37◦C with 5% CO2. Following
incubation, the medium was aspirated, replaced with fresh
medium, and sterile filtered extracts and the vehicle control
(DMSO) were serially diluted from 2 to 256 µg mL−1. Plates
were incubated for 24 h at 37◦C with 5% CO2. Cytotoxicity was
determined with a LDHAssay Kit (G-Biosciences, St. Louis, MO)
following manufacturer’s protocol. Briefly, after 24 h, 20 µL of
lysis buffer was added in triplicate and the plate was incubated
for another 45 min. Plates were centrifuged at 1500 rpm for 4
min. Following centrifugation, 50 µL of supernatant from each
well was transferred to a new 96-well plate, mixed with 50 µL
of substrate mix and incubated for 20 min while being protected
from light. After incubation, 50 µL of stop solution was added
to all wells, and absorbance was recorded at 490 nm with a plate
reader.
Characterization of Active Extracts
Preliminary characterization of the most active extracts, which
either exhibited a MIC50 or MBEC50, was pursued by HPLC.
The analysis was performed on an Agilent 1260 Infinity system
running OpenLab CDS ChemStation (Agilent Technologies,
Santa Clara, CA) with an Agilent ZORBAX Eclipse XDB-
C18 (250 mm × 4.6 mm, 5 µm) column (Santa Clara, CA)
with compatible guard column at a column temperature of
35◦C. Mobile phase reagents were HPLC grade and purchased
from Fisher Scientific (Waltham, MA), except for the Type 1
water, which was obtained from an EMD Millipore MILLI-
Q water system (Billerica, MA). Mobile phase consisted of a
linear gradient elution 0.1% formic acid in water (A) and 0.1%
formic acid in acetonitrile (B) at a flow rate of 2 mL min−1.
Initial conditions were 95:5 (A:B) changing to 63:37 (A:B) at
40 min, to 100% B at 80 min and held until 90 min. Samples
were prepared in MeOH and 10 µL or 20 µL injections were
made. Chromatograms were monitored at 254 nm and 280 nm.
Authentic standards were used to aid in peak identification by
comparison of retention times and UV profiles. Caffeic acid,
chlorogenic acid, p-coumaric acid, ellagic acid, ferulic acid, and
resveratrol were purchased from MP Biomedicals (Solon, OH)
at ≥98% purity. Gallic acid was purchased from Acros Organics
(NJ) at 98% purity. ACS grade tannic acid from Sigma Aldrich
(St. Louis, MO) was characterized prior to use by HPLC-PDA
analysis.
Liquid chromatography-Fourier transform mass
spectrometry (LC-FTMS) was performed on the MeOH
extract of Hapalopilus rutilans using a Shimadzu SIL-ACHT
(Kyoto, Japan) and Dionex 3600SD HPLC pump (Sunnyvale,
CA) with the above described chromatographic conditions.
The data was acquired in MS1 mode scanning from m/z 150
to 1500 on a Thermo Scientific LTQ-FT Ultra MS (Waltham,
MA) in negative ESI mode and processed with Thermo Scientific
Xcalibur 2.2 SP1.48 software (San Jose, CA). The capillary
temperature and voltage were 275.0◦C and −19.00 V, sheath gas
of 60, source voltage 5.0 kV, and source current 100.0 µA.
Statistical Analyses
Percent inhibition of growth and biofilm formation (screening
concentration of 256 µg mL−1) was compared for extracts sorted
into two groups: plants used for SSTI and plants those not
documented for this use. GraphPad Prism software was used to
conduct statistical tests. A Student’s t-test (unpaired, 2-tailed),
was conducted to compare percent inhibitory activity of the two
groups, with p < 0.05 considered significant. A second analysis
of the data was also performed following the removal of multiple
outliers by the ROUT method, which was more suitable to this
analysis than the Grubbs’ method as it accounts for multiple
outliers (Barnett and Lewis, 1994; Motulsky and Brown, 2006).
The false discovery rate, or “Q,” was set to 1% for this procedure.
RESULTS
A total of 10 fungal species, distributed across 10 genera and 6
families, and 58 plant species, distributed across 55 genera and 32
families were extracted and evaluated for growth inhibition and
biofilm eradication activity against P. acnes. Seventeen of these
species have been documented in the ethnobiological literature
as being used in therapies for SSTIs (Pieroni et al., 2002, 2004a,b;
Pieroni and Quave, 2005; Quave et al., 2008b); these are denoted
with a “+” in the SSTI column of Table 1.
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TABLE 1 | Minimum inhibitory concentrations (MICs) of plant extracts (µg mL−1) against Propionibacterium acnes (ATCC 6919).
Taxa [voucher code] Common Name SSTI use‡ Part Extracted† Extraction Solvent MIC50 MIC90
FUNGI
Amanitaceae
Amanita caesarea (Scop.) Pers. [AS-19] Caesar’s mushroom − fb MeOH − −
Ganodermataceae
Ganoderma lucidum (Curtis) P. Karst. [AS-10] Lingzhi mushroom − fb MeOH − −
H2O − −
Gleophyllaceae
Gloeophyllum sepiarium (Wulfen) P. Karst. [AS-4] − − fb MeOH − −
Hymenochaetales
Fuscoporia torulosa (Pers.) T. Wagner & M. Fisch. [AS-1] − − fb H2O − −
Trichaptum biforme (Fr.) Ryvarden [AS-12] − − fb MeOH − −
H2O − −
Meripilaceae
Meripilus giganteus (Pers.) P. Karst. [AS-11] Giant polypore − fb MeOH − −
H2O − −
Polyporaceae
Coriolopsis gallica (Fr.) Ryvarden [AS-13] − − fb MeOH − −
H2O − −
Fomes fomentarius (L.) Fr. [AS-4] Tinder fungus − fb MeOH − −
H2O − −
Hapalopilus rutilans (Pers.) Murrill [AS-5] Tender nesting
polypore
− fb MeOH 128 256
H2O − −
Trametes versicolor (L.) Lloyd [AS-8] Turkey tail − fb MeOH − −
H2O − −
PLANTAE
Adoxaceae
Sambucus ebulus L. [CQ-180] Dwarf Elder + infl EtOH − −
MeOH − −
le EtOH − −
MeOH − −
st EtOH − −
Sambucus nigra L. [CQ-151] Elderberry + fr EtOH − −
MeOH − −
le EtOH − −
MeOH − −
wp EtOH − −
infl MeOH − −
Amaryllidaceae
Allium cepa L. [CQ-206] Onion + le; bu EtOH − −
MeOH − −
Apiaceae
Daucus carota L. [CQ-215] Queen Anne’s lace − le; st EtOH − −
MeOH − −
infl; infr EtOH − −
Ferula communis L. [CQ-214] Giant fennel − fr EtOH − −
st EtOH − −
MeOH − −
infl MeOH − −
ro MeOH − −
Foeniculum vulgare subsp. piperitum Cout. [CQ-192] Fennel − le; st EtOH − −
(Continued)
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TABLE 1 | Continued
Taxa [voucher code] Common Name SSTI use‡ Part Extracted† Extraction Solvent MIC50 MIC90
Foeniculum vulgare subsp. vulgare [CQ-196] Fennel − le; st EtOH − −
MeOH − −
Apocynaceae
Vinca major L. [CQ-139] Bigleaf periwinkle − le; st; ro MeOH − −
Araceae
Arum italicum Mill. [CQ-175] Italian lords and
ladies
− st EtOH − −
fr EtOH − −
sta EtOH − −
le EtOH − −
MeOH − −
Asparagaceae
Leopoldia comosa (L.) Parl. [CQ-105] Tassel hyacinth − le; infl MeOH − −
bu MeOH − −
Asteraceae
Achillea millefolium L. [CQ-176] Common yarrow + infl EtOH − −
le; st EtOH − −
le; st; fl EtOH − −
MEOH − −
Anacyclus tomentosus (Gouan) DC. [CQ-167] Whitebuttons − le; st; fl EtOH − −
Cichorium intybus L. [CQ-161] Chicory − le; st; fl EtOH − −
Scolymus hispanicus L. [CQ-199] Common
goldenthistle
− le; st; fl EtOH − −
MeOH − −
Tussilago farfara L. [CQ-202] Coltsfoot − le; st; ro EtOH − −
le; st; fl MeOH − −
Brassicaceae
Cardaria draba (L.) Desv. [CQ-108] Whitetop − fl; st; le; ro MeOH − −
Caprifoliaceae
Dipsacus fullonum L. [CQ-201] Fuller’s teasel − le; st EtOH − −
MeOH − −
fl EtOH − −
Knautia arvensis J.M. Coult. [CQ-190] Field scabiosa − le;st;fl EtOH − −
Knautia lucana Lacaita & Szabó [CQ-166] − − le; st; fl EtOH − −
MeOH − −
Lonicera alpigena L. [CQ-213] Alpine honeysuckle − wp EtOH − −
MeOH − −
le EtOH − −
Caryophyllaceae
Saponaria officinalis L. [CQ-210] Bouncingbet − le; st; fl EtOH − −
MeOH − −
Dennstaedtiaceae
Pteridium aquilinum (L.) Kuhn [CQ-211] Western
brackenfern
− st MeOH − −
Fabaceae
Acacia dealbata Link [CQ-115] Silver wattle − infl MeOH − −
le MeOH − −
st MeOH − −
Anthyllis vulneraria L. [CQ-147] Common
kidneyvetch
− le; st; fl EtOH − −
MeOH − −
Astragalus monspessulanus L. [CQ-112] Montpellier milk
vetch
− fl; le; ro; st EtOH − −
MeOH − −
(Continued)
Frontiers in Pharmacology | www.frontiersin.org 6 November 2016 | Volume 7 | Article 425
Nelson et al. Anti-Acne Activity of Italian Plants and Fungi
TABLE 1 | Continued
Taxa [voucher code] Common Name SSTI use‡ Part Extracted† Extraction Solvent MIC50 MIC90
Coronilla emerus L. [CQ-137] Scorpion senna − wst EtOH − −
MeOH − −
le; fl MeOH − −
Melilotus albus Medik. [CQ-193] Sweetclover − le; st; fl EtOH − −
MeOH − −
Trifolium spp. [CQ-185] − − le; st; fl EtOH − −
MeOH − −
Robinia pseudoacacia L. [CQ-155] Black locust − le MeOH − −
Vicia sativa subsp. sativa [CQ-119] Garden vetch − le; st; fl MeOH 128 256
Fagaceae
Castanea sativa Mill. [CQ-191] Sweet Chestnut + le EtOH 256 −
MeOH 256 −
*Fraction 224C-F2 256 256
H2O − −
gle EtOH − −
MeOH 256 −
wp EtOH − −
MeOH 128 −
Quercus cerris L. [CQ-228; CQ-301] European turkey oak − st; fr EtOH − −
le MeOH − −
Gentianaceae
Centaurium pulchellum (Sw.) Druce [CQ-217] Branched centaury − le; ro; st; fl EtOH − −
Hypericaceae
Hypericum perforatum L. [CQ-183] St. John’s Wort + le; st; fl EtOH − −
MeOH − −
Juglandaceae
Juglans regia L. [CQ-181] Walnut + le EtOH − −
MeOH − −
wp EtOH 256 256
MeOH 128 256
imfr MeOH − −
Juncaceae
Juncus articulatus L. [CQ-216] Jointleaf rush − le; fr EtOH − −
Lamiaceae
Ballota nigra L. [CQ-160] Black horehound + ro MeOH − −
le MeOH − −
st MeOH − −
Marrubium vulgare L. [CQ-170] Horehound + ro MeOH − −
le; st; fl MeOH − −
Mentha spicata L. [CQ-224] Spearmint − le; st; fl EtOH − −
Rosmarinus officinalis L. [CQ-113] Rosemary + le; st; fl MeOH 128 256
Liliaceae
Lilium candidum L. [CQ-174] Madonna lily − infl EtOH − −
Malvaceae
Malva sylvestris L. [CQ-156] Common mallow + le MeOH − −
st MeOH − −
Moraceae
Ficus carica L. [CQ-173] Edible fig + le EtOH − −
wp EtOH − −
MeOH − −
imfr MeOH − −
(Continued)
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TABLE 1 | Continued
Taxa [voucher code] Common Name SSTI use‡ Part Extracted† Extraction Solvent MIC50 MIC90
Nyctaginaceae
Mirabilis jalapa L. [CQ-222] Four o’clock flower − le; fl; fr EtOH − −
MeOH − −
Oleaceae
Olea europaea L. [CQ-197] Olive − wp EtOH − −
MeOH − −
le MeOH − −
Plantaginaceae
Plantago major L. [CQ-225] Boradleaf plantain + le; ro; fl; st EtOH − −
MeOH − −
Poaceae
Agropyron repens (L.) P. Beauv. [CQ-208] Couch grass − le; st; ro EtOH − −
Arundo donax L. [CQ-146] Giant reed + le; st MeOH − −
in MeOH − −
Ranunculaceae
Delphinium fissum Waldst. [CQ-187] − − le; st; fl; fr EtOH − −
Ranunculus acris L. [CQ-135] Meadow buttercup − le; st; fl MeOH − −
Rosaceae
Prunus spinosa L. [CQ-163] Blackthorn - wp; le EtOH − −
fr MeOH − −
Rosa canina var. canina [CQ-152] Dog rose wp MeOH − −
80% MeOH − −
ga MeOH − −
le 80% MeOH − −
fr MeOH − −
le; fl 80% MeOH − −
Rubus ulmifolius Schott. Elmleaf blackberry + ro EtOH − −
*Fraction 220D-F2 − −
MeOH − −
wst EtOH − −
Rubiaceae
Galium verum L. [CQ-177] Yellow bedstraw + le; st; fl EtOH − −
MeOH − −
Scrophulariaceae
Verbascum thapsus L. [CQ-172] Great mullein − le MeOH − −
Ulmaceae
Ulmus minor Mill. [CQ-195] Field elm − wp EtOH − −
MeOH − −
le MeOH − −
Vitaceae
Vitis vinifera var. aglianico [CQ-209] Grape vine − le MeOH 64 64
Xanthorrhoeaceae
Asphodelus microcarpus Salzm. & Viv. [CQ-109] - + infl MeOH − −
le MeOH 128 128
ANTIBIOTIC CONTROLS
Clindamycin 0.25 2
Erythromycin 0.063 2
Resveratrol 100 100
Part Extracted
†
: bu, bulb; fl, flowers; gle, gall infected leaves; imfr, immature fruit; in, inter nodes; infl, inflorescence; infr, infructescence; fb, fruiting body; ga, galls; le, leaves; ro, roots;
st, stems; sta, stalk; wp, woody parts; wst, woody stem. SSTI use‡: “+” indicates that there is a documented ethnobotanical use for skin and soft tissue infections (SSTI) or skin
inflammations for this species; “−“ indicates no documented use for SSTIs. *The extraction protocol for 224C-F2 and 220D-F2 have been previously published (Quave et al., 2012,
2015). The MIC for growth is represented at MIC50 (or at 50% inhibition of the growth control) or MIC90 for 90% inhibition. “−“ indicates that the MIC50 was not detected in the
concentration range tested (2-256 µg mL−1). None of the extracts tested exhibited MBEC50 within the tested concentration range, and thus this column is omitted from the table.
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Anti-Bacterial Activity
Growth Inhibition
MIC50 and MIC90 values were detected for one fungus
(Hapalopilus rutilans) and 6 plants (Vicia sativa subsp. sativa,
C. sativa, Juglans regia, Rosmarinus officinalis, Vitis vinifera var.
aglianico, andAsphodelus microcarpus) at the tested range (2–256
µg mL−1). The extraction method and plant or fungal tissue(s)
extracted for each species, as well as all MICs for extracts and
controls are reported in Table 1.
The most active extract in terms of growth inhibition included
a leaf extract ofV. vinifera var. aglianico, with aMIC50 andMIC90
value of 64µg mL−1. Extracts withMIC50 values of 128µg mL
−1
included Hapalopilus rutilans (MeOH extract of fruiting body),
V. sativa subsp. sativa (MeOH extract of aerial parts), J. regia
(MeOH extract of woody parts), R. officinalis (MeOH extract of
aerial parts) andA.microcarpus (MeOH extract of leaves). Several
extracts derived from the leaves and woody parts of C. sativa
also exhibited MIC50 values ranging from 128 to 256 µg mL
−1.
Positive controls clindamycin and erythromycin exhibitedMIC50
of 0.25 µg mL−1 and 0.063 µg mL−1, respectively, and MIC90 of
2 µg mL−1, while resveratrol exhibited an MIC50 and MIC90 of
100 µg mL−1.
Biofilm Eradication
None of the extracts tested exhibited at least 50% eradication
of mature biofilm within the tested concentration range. The
positive control for biofilm eradication (resveratrol) exhibited
MBEC50 and MBEC90 of 100 µg mL
−1.
Comparison of Activity Based on Traditional Use
Initial screening of Italian plants and fungi in the QNPL was
conducted at 256 µg mL−1, resulting in percent inhibition values
for both growth and biofilm. Extracts were sorted into two
groups, based on history of traditional medicinal use for acne
and other SSTIs in Italy. Extracts from plants used in traditional
therapies for skin infections exhibited a mean value of 38%
inhibition of growth, which was significantly greater (p < 0.001)
than that of extracts from randomly selected plants and fungi
(12%), Figure 1A. Likewise, there was a significant difference
(p < 0.05) in biofilm eradicating activity between both groups
(10% in SSTI versus 5% in random, Figure 1B). Outliers in
the data set were also identified and removed by the ROUT
method and then reassessed using a Student’s t-test. Five outliers
were identified and removed from the growth inhibitory data,
and the groups were found to be significantly different (p <
0.0001), Figure 1C. Three outliers were identified and removed
in the biofilm datasets, also reconfirming a significant difference
between groups (p< 0.001), Figure 1D.
Mammalian Cytotoxicity
Extracts with MIC50 values detected were examined for
cytotoxicity against an immortalized line of human keratinocytes
at a test range of 2–256 µg mL−1 in order to determine
whether the observed antibacterial activity was due to specific
antibacterial action or general toxicity. The only extracts to
exhibit an IC50 came from J. regia and Hapalopilus rutilans,
both at the highest test dose of 256 µg mL−1 (Figure 2). All
other extracts tested exhibited limited to no toxicity at the
concentrations necessary for antibacterial activity.
Chemical Characterization of Active
Extracts
We used a panel of ubiquitous chemical standards in effort to
provide basic chemical characterization of extracts of interest.
The most bioactive extracts were examined for the presence
of caffeic acid (1), chlorogenic acid (2), p-coumaric acid (3),
ellagic acid (4), ferulic acid (5), gallic acid (6), resveratrol (7),
and tannic acid (8) by comparison with authentic standards
by HPLC-DAD. The presence or absence of these standards in
extracts is reported in Table 2. Several extracts derived from C.
sativa were active as growth inhibitors for P. acnes. Ellagic acid
(4) and gallic acid (6) were both detected in all of the C. sativa
extracts (Supplementary Figure 1B). More detailed chemical
characterization of the most active extract fraction, 224C-F2, is
reported in a recent publication concerning its anti-virulence
effects against S. aureus (Quave et al., 2015).
The H. rutilans extract underwent further characterization
using negative ESI LC-FTMS. The [M-H]− for 9 was determined
to be 291.06755, providing an empirical formula of C18H11O4(1
2.365). Comparison with published literature identified 9 as
the antitumor and dihydroorotate dehydrogenase inhibitor
polyporic acid, which can account for up to 40% of the fungal
fruiting body’s mass (Kraft et al., 1998).
DISCUSSION
The central aim of this study was to determine whether or
not extracts that are derived from plants or fungi used in
topical skin therapeutics for acne and other forms of SSTI in
traditional medicine would have greater activity against P. acnes
than specimens from a random sample. Our hypothesis was
supported; we found that extracts of plants used for traditional
anti-infective skin therapeutics had a significantly greater impact
on planktonic growth and on mature biofilms of P. acnes than
extracts from random samples (including medicinal plants used
for other purposes unrelated to the skin). Here, we discuss some
of the specific sources of bioactivity reported in this study and
make recommendations for future investigation.
Of the 157 extracts screened in this study, 12 exhibited more
than 50% growth inhibition at the test concentration range. These
twelve came from one fungus and six plant species. The bioactive
fungal species is a polypore fungus, and is also known by the
common names of tender nesting polypore, purple dye polypore,
or the cinnamon bracket. While some other polypore fungi (i.e.,
Trametes versicolor, also known as Turkey tail) can play an
important role as cosmetic or cosmeceutical ingredients (Hyde
et al., 2010), to the best of our knowledge, there are no reports
of such uses for H. rutilans. Although nothing has been reported
concerning topical toxicity or contact dermatitis with this species,
multiple reports on poisoning events following consumption of
this fungus have been reported, and include symptoms such
as purple discoloration of the urine, nausea, vomiting, blurred
visions, hallucinations, and even death (Kraft et al., 1998; Villa
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FIGURE 1 | Extracts were screened for percent inhibitory activity against (A) growth and (B) biofilm at a concentration of 256µg mL−1. Outlier data points
were identified using the ROUT method, removed and the data-set reanalyzed for (C) growth and (D) biofilm activity. *p < 0.05; **p < 0.01; ***p < 0.001; ****p <
0.0001.
et al., 2013). Such neurotoxic effects have been attributed to the
high content of polyporic acid in the fungus, which was also
identified as the principal component of the extract evaluated in
the present study (65.74% of the crude extract, representing 5.7%
of dry mass of the fruiting body). While the extract of this species
inhibited P. acnes growth (MIC50 128 µg mL
−1) and inhibited
mature biofilm by 45% at a concentration of 256 µg mL−1, it
also exhibited cytotoxicity to skin cells (HaCaT) (IC50 of 256 µg
mL−1) at or near concentrations inhibitory to P. acnes, suggesting
that the activity observed is due to general toxicity of the extract.
While none of the plant species examined were effective at
eradicating mature P. acnes biofilm, we did identify five species
with growth inhibitory activity at concentrations that were non-
toxic to HaCaTs. The most active was a leaf extract from the
aglianico grape varietal (V. vinifera var. aglianico) with a MIC50
and MIC90 of 64 µg mL
−1. No cytotoxicity was detected against
HaCaT cells at that concentration and only 40% cytotoxicity
was reached at the highest concentration tested (256 µg mL−1).
Among the standards included in our chemical characterization
studies, 3, 4, 6, and 8 were all detected in this extract. It is
unlikely that 4, 6, or 8 were individually responsible for the
growth inhibitory activity observed as the MIC for these against
another strain of P. acnes was reported as 800, 1800, and 1000 µg
mL−1, respectively (Patil et al., 2012).While 7was not detected in
this leaf extract, it is known to be found in grapevine, particularly
the grape skin. It has been identified as having growth inhibitory
and biofilm-eradicating activity against P. acnes (Coenye et al.,
2012). This is the first report of grape leaf extracts exhibiting
growth inhibitory effects. The interactions between grapevine
and P. acnes are quite interesting, especially considering recent
phylogenetic and population genetic research that suggests a
horizontal interkingdom transfer of this human opportunistic
pathogen to grapevine as an obligate endophyte during the period
in which this species was domesticated by humans (Campisano
et al., 2014). Further studies on anti-acne activity of this extract
and its individual constituents are warranted.
Another active extract came from V. sativa subsp. sativa
(Garden vetch), and it exhibited a MIC50 and MIC90 against
P. acnes at concentrations of 128 and 256 µg mL−1, respectively.
The IC50 for cytotoxicity to skin cells (HaCaT) was not detectable
at this test range. HPLC analysis revealed low levels of 6 and 8, as
well as a number of larger peaks that should be prioritized for
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FIGURE 2 | The most active extracts were examined for mammalian cytotoxicity against an immortalized line of human keratinocytes (HaCaT). Data
are reported as percent cytotoxicity and the vehicle (DMSO) was included as a control. Extract numbers correspond as follows: (A) 195: Juglans regia (EtOH extract
of woody parts); 246: Asphodelus microcarpus (MeOH extract of leaves). (B) 252: Castanea sativa (MeOH extract of woody parts); and 275: Juglans regia (MeOH
extract of woody parts). (C) Extract numbers: 311: Rosmarinus officinalis (MeOH extract of aerial parts: leaves, stems, flowers); 336: Vitis vinifera var. aglianico (MeOH
extract of leaves). (D) 357: Vicia sativa subsp. sativa (MeOH extract of aerial parts: leaves, stems, flowers); and 516: Hapalopilus rutilans (MeOH extract of fruiting
bodies). Castanea sativa leaf extracts were found to be non-toxic at the tested range and this data is reported in a previous work (Quave et al., 2015).
TABLE 2 | Chemical characterization of the most bioactive extracts.
Source Extract Extraction detail 1 2 3 4 5 6 7 8
Asphodelus microcarpus Salzm. & Viv. 246 MeOH extract of leaves − + + + − − − −
Castanea sativa Mill. 134 EtOH extract of leaves − − − + − + − −
224 MeOH extract of leaves − − − + − + − −
224C Ethyl acetate partition of 224 − − − + − + − −
224C−F2 Flash chromatography fraction of 224C − − − + − + − −
252 MeOH extract of woody parts − − − + − + − −
Hapalopilus rutilans (Pers.) Murrill 516 MeOH extract of fruiting bodies − − − − − − − −
Juglans regia L. 195 EtOH extract of woody parts − − − + − − − +
275 MeOH extract of woody parts − − − − − − − −
Rosmarinus officinalis L. 311 MeOH extract of aerial parts (leaves, stems, flowers) − − − − − − − −
Vicia sativa subsp. sativa 357 MeOH extract of aerial parts (leaves, stems, flowers) − − − − − + − +
Vitis vinifera var. aglianico 336 MeOH extract of leaves − − + + − + − +
Samples were examined by HPLC and compared to the following standards: caffeic acid (1), chlorogenic acid (2), p-coumaric acid (3), ellagic acid (4), ferulic acid (5), gallic acid (6),
resveratrol (7), tannic acid (8). Compounds identified in the extract are denoted by “+”, those absent by “−“. Chromatograms are reported in Supplementary Figure 1 and structures
in Supplementary Figure 2.
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identification in future studies. Garden vetch is most widely used
as fodder for livestock (esp. for horses and cattle). It has been
previously examined for antibacterial, anti-biofilm, and quorum-
sensing inhibitory effects against S. aureus, with no detected
activity (Quave et al., 2008a, 2011). Further investigation of this
non-toxic and abundantly available fodder crop as a potential
acne therapy is merited.
Bioactivity of Medicinal Plants used in
Traditional Treatment of SSTI
The remaining four active species of interest—C. sativa (Sweet
Chestnut), J. regia (Walnut), R. officinalis (Rosemary), and
A. microcarpus—exhibited MIC50 values of 128–256 µg mL
−1
and all have indications for traditional use in the topical
treatment of skin infections and inflammations as documented
in ethnobotanical studies conducted in Italy (e.g., Pieroni et al.,
2002, 2004a,b; Quave et al., 2008b).
Different traditional preparations of Sweet Chestnut
(C. sativa) have been documented in ethnopharmacological
studies in Italy for topical applications as an emollient, anti-
inflammatory, skin-whitener, and anti-eczema treatment. The
antibacterial activity of chestnut extracts has been reported
against a number of pathogens (Basile et al., 2000), and more
recently, attention has shifted to activity in blocking virulence
pathways in S. aureus (Quave et al., 2015). The non-toxic
nature of the chestnut leaf extracts assessed here, along with its
combined role in inhibiting both staphylococcal virulence and
growth of P. acnes makes it an interesting candidate for further
analysis.
Walnut trees (J. regia), on the other hand, have been
documented for topical use as an anti-fungal (particularly for
fungal infections of the feet), antiseptic, compress, and as a
colorant (for hair). The cytotoxicity (IC50 of 256 µg mL
−1) of
this particular walnut extract against skin cells (HaCaT) suggests
general toxicity, and thus is not a high priority for further study.
Rosemary (R. officinalis) is used traditionally as a hair wash,
facial toner, foot bath and general skin tonic. Previous research
on this specific rosemary extract demonstrated both mild growth
inhibitory (MIC50 of 512 µg mL
−1) and biofilm inhibitory
(MBIC50 of 64 µg mL
−1) activity against S. aureus (Quave
et al., 2008a). Inhibition of delta-toxin production (IC50 of 64
µg mL−1), a virulence factor controlled by S. aureus quorum
sensing, was also detected for this extract (Quave et al., 2011).
The growth inhibitory activity of rosemary extracts and essential
oils against P. acnes has been reported in a number of studies
(Fu et al., 2007; Weckesser et al., 2007; Tsai et al., 2013). Due
to its common incorporation as an ingredient in skin and hair
care ingredients, further investigation of its anti-acne activity is
warranted.
Lastly, A. microcarpus also demonstrated growth inhibitory
activity without notable toxicity to keratinocytes. It has been
reported in the ethnobotanical literature for use as a diuretic, for
otitis and toothache in Algeria (Sarri et al., 2014), a wild food
source in theMedieval Levant (Rubin, 2002) and a skin emollient,
lenitive and treatment for lung diseases in Sardinia (Loi et al.,
2005). Extracts and individual compounds extracted from the
tubers of A. microcarpus have demonstrated antimicrobial
(against S. aureus and Cryptococcus neoformans) and anti-
malarial (against Plasmodium falciparum) activities (Ghoneim
et al., 2013), but this is the first study to document its antibacterial
properties against P. acnes.Due to its favorable therapeutic index
(activity:toxicity), this species alsomerits further investigation for
potential anti-acne applications.
CONCLUSIONS
In conclusion, we have demonstrated that plants and fungi used
in the traditional treatment of acne and other SSTIs exhibit
higher levels of activity than plants with no relevant ethno-use,
thus validating the ethnobotanical approach as a useful drug
discovery tool. Specifically, we found a statistically significant
difference in growth inhibition and biofilm eradication of P. acnes
by plants and fungi used in traditional medicine to treat SSTIs
in comparison to a random sample of plants and fungi with
other unrelated (or no) human uses. Furthermore, we identified
seven species with growth inhibitory activity. However, two of
these were determined to be cytotoxic. An additional two have
already been reported in the literature for their anti-acne activity
(Fu et al., 2007; Weckesser et al., 2007; Coenye et al., 2012; Tsai
et al., 2013). This study was the first to document the growth
inhibitory activity of organic extracts of V. sativa aerial parts,
V. vinifera leaves and A. microcarpus leaves. Further research on
the bioactivity of these extracts and their individual constituents
are planned in future work as there is a need for new therapeutics
for P. acnes.
AUTHOR CONTRIBUTIONS
KN and CQ wrote the manuscript. AS collected and assigned
taxonomic identities to fungal samples. CQ collected and
identified all plant samples. PT performed chemical extractions of
fungal samples. TL, EA-N, and KN performed plant extractions
and microbiological and cell culture experiments. JL performed
chemical and chromatographic analyses on the active extracts.
CQ, KN, and JL performed data analyses. All authors read,
revised, and approved of the final manuscript.
FUNDING
This work was supported by the Bionorica SE Global Research
Initiative (Project title: Botanical natural product inhibitors of
acne biofilms). The funding agency had no role in the design,
implementation or analysis of the study.
ACKNOWLEDGMENTS
Thanks to T. Coenye for assistance with the P. acnes biofilm
protocol. Thanks to Dr. R. Schinazi and Dr. S. Tao for assistance
with the mass spectrometry analysis. Thanks to Dr. B. Pollack for
provision of the HaCaT cell line used in this study.
Frontiers in Pharmacology | www.frontiersin.org 12 November 2016 | Volume 7 | Article 425
Nelson et al. Anti-Acne Activity of Italian Plants and Fungi
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fphar.
2016.00425/full#supplementary-material
Supplementary Figure 1 | UV-Vis chromatograms of bioactive extracts
with standards identified. Standards shown here include chlorogenic acid (2),
p-coumaric acid (3), ellagic acid (4), gallic acid (6) and tannic acid (8). Polyporic
acid (9) was identified by LC-FTMS. (A) Extract numbers correspond as follows.
195: Juglans regia (EtOH extract of woody parts); 246: Asphodelus microcarpus
(MeOH extract of leaves); 252: Castanea sativa (MeOH extract of woody parts);
and 275: Juglans regia (MeOH extract of woody parts); 311: Rosmarinus officinalis
(MeOH extract of aerial parts: leaves, stems, flowers); 336: Vitis vinifera var.
aglianico (MeOH extract of leaves); 357: Vicia sativa subsp. sativa (MeOH extract
of aerial parts: leaves, stems, flowers); and 516: Hapalopilus rutilans (MeOH
extract of fruiting bodies). (B) A number of different extracts derived from a single
species, Castanea sativa, were evaluated. Extract numbers correspond as
follows. 134: EtOH extract of leaves; 226: MeOH extract of gall-infected leaves;
224: MeOH extract of leaves; 224C: ethyl acetate partition of 224; 224C-F2: flash
chromatography fraction of 224C; 252: MeOH of woody parts.
Supplementary Figure 2 | Compounds identified in the bioactive extracts,
as reported in Table 2 and Supplementary Figure 1: chlorogenic acid (2),
p-coumaric acid (3), ellagic acid (4), gallic acid (6), tannic acid (8), and
polyporic acid (9).
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